Dr. Cho worked as a hospitalist at Cleveland Clinic before moving to Cedars-Sinai to complete his PhD in biomedical and translational science and his cardiology fellowship training, according to a Feb. 17 news release.
“Dr. Cho’s addition to the faculty at the Smidt Heart Institute helps further our commitment to translational medicine, which combines benchside research with bedside care,” said Eduardo Marbán, MD, PhD, executive director of the Smidt Heart Institute.
The physician-scientist is currently investigating the possibility of using cell therapy to regenerate healthy heart muscles, reduce abnormal rhythms and improve heart function among heart failure patients with preserved ejection fraction.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
